青少年和年轻成人结节性淋巴细胞为主型霍奇金淋巴瘤的治疗模式与结局:IMPACT队列研究
该研究利用加拿大安大略省基于人群的临床和医疗数据,识别1992至2012年诊断时年龄15-21岁的结节性淋巴细胞为主型霍奇金淋巴瘤(NLPHL)青少年和年轻成人(AYA),收集临床数据并链接医疗数据库以识别后续恶性肿瘤、复发和死亡。1014例霍奇金淋巴瘤AYA中54例(5.3%)为NLPHL,20年无事件生存率和总生存率分别为82.9%±5.2%和100%,晚期阶段与较差的无事件生存相关(HR 4.9,95%CI 1.3-18.4,P=0.02),仅切除治疗的患者中无后续恶性肿瘤发生。
要点
- 1014例霍奇金淋巴瘤AYA中54例(5.3%)为NLPHL,15例(27.8%)在儿科中心治疗。
- 儿科中心无患者仅接受放疗,成人中心16例(41.0%)仅接受放疗,仅切除在儿科中心更常见(P<0.001)。
- 20年无事件生存率和总生存率分别为82.9%±5.2%和100%,晚期阶段与较差无事件生存相关(HR 4.9,95%CI 1.3-18.4,P=0.02)。
核心结论
- NLPHL的AYA患者长期生存极好,仅切除在儿科机构之外罕见但与极好结局相关。
- 鉴于后续恶性肿瘤风险显著,作者认为对合适患者亚群采用避免化疗和避免放疗的策略是合理的。
研究设计与样本
- 基于人群的队列研究,利用加拿大安大略省临床和医疗数据识别1992至2012年诊断时年龄15-21岁的NLPHL患者。
- 共识别1014例霍奇金淋巴瘤AYA,其中54例(5.3%)为NLPHL,15例(27.8%)在儿科中心治疗。
- 链接医疗数据库识别后续恶性肿瘤、复发和死亡,按治疗地点(成人vs儿科)比较无事件生存率和总生存率并确定结局预测因素。
主要发现
- 儿科中心无患者仅接受放疗,成人中心16例(41.0%)仅接受放疗,仅切除在儿科中心更常见(P<0.001)。
- 20年无事件生存率和总生存率分别为82.9%±5.2%和100%。
- 晚期阶段与较差无事件生存相关(HR 4.9,95%CI 1.3-18.4,P=0.02)。
- 整个队列25年后续恶性肿瘤累积发生率为19.3%±9.6%,仅切除治疗的患者中无后续恶性肿瘤发生。
临床怎么用
- 作者认为,鉴于后续恶性肿瘤风险显著,对合适患者亚群采用避免化疗和避免放疗的策略是合理的。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We leveraged population-based clinical and healthcare data to identify treatment patterns and long-term outcomes among adolescents and young adults (AYA) with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). All Ontario, Canada, AYA aged 15-21 years at diagnosis with NLPHL between 1992 and 2012 were identified, and their detailed clinical data were collected. Linkage to healthcare databases identified additional events (subsequent malignant neoplasms [SMN], relapses and deaths). Event-free survival (EFS) and overall survival (OS) were compared by locus of care (adult vs. paediatric) and predictors of outcomes determined. Of 1014 AYA with Hodgkin lymphoma, 54 (5.3%) had NLPHL; 15 (27.8%) were treated at a paediatric centre. No paediatric centre patient received radiation only versus 16 (41.0%) of adult centre patients. Excision only was more common in paediatric centres (p < 0.001). The 20-year EFS and OS rates were 82.9% ± 5.2% and 100% respectively. Advanced stage (hazard ratio: 4.9, 95% CI: 1.3-18.4; p = 0.02) was associated with inferior EFS. Although the 25-year cumulative incidence of SMN was 19.3% ± 9.6% for the entire cohort, there were no SMN among the patients treated with excision only. AYA with NLPHL have outstanding long-term survival. Resection alone was rare outside of paediatric institutions but associated with excellent outcomes. Given substantial SMN risks, chemotherapy-sparing and radiation-sparing strategies for appropriate subsets of patients are warranted.
引用
- Punnett A, Baxter NN, Hodgson D, et al. Treatment patterns and outcomes in adolescents and young adults with nodular lymphocyte-predominant Hodgkin lymphoma: an IMPACT cohort study. Br J Haematol. 2023. PMID: 37015867. doi:10.1111/bjh.18757
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。